Ved initiering eller seponering af carbamazepin eller andre andre stoffer, som inducerer leverenzymet CYP 3A4/ P- glykoprotein (P- gp), bør doseringen af RISPERDAL CONSTA reevalueres.
Due to the known efficacy and safety profile of risperidone, this additional dose is approvable without its own efficacy data and can be based solely on the PK data.